Atrium Therapeutics, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
13.00
-0.09 (-0.69%)
May 26, 2026, 1:42 PM EDT - Market open
Atrium Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Atrium Therapeutics stock have an average target of $25, which predicts a 92.31% increase from the current stock price of 13.
Price Target: $25 (+92.31%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Atrium Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | May '26 |
|---|---|---|
| Strong Buy | 1 | 2 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +92.31% | May 15, 2026 |
| Wells Fargo | Wells Fargo | Buy Initiates $25 | Buy | Initiates | $25 | +92.31% | Mar 10, 2026 |
Financial Forecast
Revenue This Year
8.08M
from 18.62M
Decreased by -56.60%
Revenue Next Year
8.08M
from 8.08M
EPS This Year
-4.18
from -3.19
EPS Next Year
-4.67
from -4.18
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 |
|---|---|---|
| High | 8.4M | 8.4M |
| Avg | 8.1M | 8.1M |
| Low | 7.8M | 7.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 |
|---|---|---|
| High | -54.9% | 4.0% |
| Avg | -56.6% | - |
| Low | -57.9% | -3.0% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | -4.35 | -4.85 |
| Avg | -4.18 | -4.67 |
| Low | -4.06 | -4.53 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.